GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been assigned a consensus rating of “Moderate Buy” from the twenty brokerages that are presently covering the stock, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $79.4762.

GEHC has been the subject of a number of research reports. BMO Capital Markets initiated coverage on GE HealthCare Technologies in a research note on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price objective for the company. Citigroup restated a “neutral” rating on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. The Goldman Sachs Group reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. BTIG Research reiterated a “buy” rating and set a $75.00 price target on shares of GE HealthCare Technologies in a research note on Monday. Finally, Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, April 30th.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $65.31 on Tuesday. The firm’s 50 day moving average price is $63.52 and its 200-day moving average price is $72.45. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. GE HealthCare Technologies has a one year low of $58.75 and a one year high of $89.77. The firm has a market cap of $29.71 billion, a P/E ratio of 15.62, a P/E/G ratio of 1.76 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same period in the previous year, the business posted $1.01 EPS. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities research analysts predict that GE HealthCare Technologies will post 4.89 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is presently 3.35%.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CFO James Saccaro purchased 3,310 shares of the firm’s stock in a transaction on Friday, May 1st. The stock was bought at an average price of $60.60 per share, with a total value of $200,586.00. Following the transaction, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This represents a 3.93% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kevin Lobo purchased 10,000 shares of the company’s stock in a transaction on Friday, May 22nd. The stock was acquired at an average price of $64.18 per share, with a total value of $641,800.00. Following the purchase, the director owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This represents a 229.20% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 21,847 shares of company stock worth $1,361,355 over the last 90 days. 0.36% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of GEHC. Laurel Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at about $26,000. Optima Capital LLC purchased a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $27,000. Godfrey Financial Associates Inc. acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth about $27,000. Montag A & Associates Inc. grew its position in shares of GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after buying an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC increased its stake in shares of GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after buying an additional 262 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.